Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
alkaloid
antitussive |
| gptkbp:ATCCode |
R05DA07
|
| gptkbp:availableOn |
gptkb:sugar
gptkb:tablet capsule injection |
| gptkbp:CASNumber |
128-62-1
|
| gptkbp:chemicalFormula |
C22H23NO7
|
| gptkbp:compatibleWith |
opioid
narcotic |
| gptkbp:contraindication |
children under 2 years
patients with hypersensitivity |
| gptkbp:discoveredBy |
gptkb:Pierre_Robiquet
|
| gptkbp:excretion |
kidneys
|
| gptkbp:foundIn |
gptkb:Papaver_somniferum
|
| https://www.w3.org/2000/01/rdf-schema#label |
noscapinum
|
| gptkbp:IUPACName |
gptkb:(3S)-6,7-dimethoxy-3-[(5R)-4-methoxy-6-methyl-5,6,7,8-tetrahydro-5,11-methanoazepino[1,2-a]isoquinolin-12(5H)-yl]-2-benzofuran-1(3H)-one
|
| gptkbp:legalStatus |
OTC in some countries
|
| gptkbp:meltingPoint |
176°C
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
413.42 g/mol
|
| gptkbp:sideEffect |
nausea
allergic reaction drowsiness |
| gptkbp:usedAs |
cough suppressant
|
| gptkbp:bfsParent |
gptkb:noscapine
|
| gptkbp:bfsLayer |
7
|